Search by Drug Name or NDC

    NDC 45802-0109-01 Triamcinolone Acetonide Nasal 55 ug/1 Details

    Triamcinolone Acetonide Nasal 55 ug/1

    Triamcinolone Acetonide Nasal is a NASAL SPRAY, METERED in the HUMAN OTC DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is TRIAMCINOLONE ACETONIDE.

    Product Information

    NDC 45802-0109
    Product ID 45802-109_6144fe71-93f5-4b2d-a3f2-8be6cd67e32c
    Associated GPIs 42200060103210
    GCN Sequence Number 072054
    GCN Sequence Number Description triamcinolone acetonide SPRAY 55 MCG NASAL
    HIC3 Q7P
    HIC3 Description NASAL ANTI-INFLAMMATORY STEROIDS
    GCN 36145
    HICL Sequence Number 002891
    HICL Sequence Number Description TRIAMCINOLONE ACETONIDE
    Brand/Generic Generic
    Proprietary Name Triamcinolone Acetonide Nasal
    Proprietary Name Suffix n/a
    Non-Proprietary Name Triamcinolone acetonide
    Product Type HUMAN OTC DRUG
    Dosage Form SPRAY, METERED
    Route NASAL
    Active Ingredient Strength 55
    Active Ingredient Units ug/1
    Substance Name TRIAMCINOLONE ACETONIDE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078104
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0109-01 (45802010901)

    NDC Package Code 45802-109-01
    Billing NDC 45802010901
    Package 1 BOTTLE in 1 CARTON (45802-109-01) / 120 SPRAY, METERED in 1 BOTTLE
    Marketing Start Date 2017-03-28
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.74375
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description TRIAMCINOLONE 55 MCG NASAL SPR
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis